| 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary … M Valgimigli, H Bueno, RA Byrne, JP Collet, F Costa, A Jeppsson, P Jüni, ... European heart journal 39 (3), 213-260, 2018 | 3189 | 2018 |
| ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular … Authors/Task Force Members, L Rydén, PJ Grant, SD Anker, C Berne, ... European heart journal 34 (39), 3035-3087, 2013 | 2357 | 2013 |
| Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance EI Lev, RT Patel, KJ Maresh, S Guthikonda, J Granada, T DeLao, PF Bray, ... Journal of the American College of Cardiology 47 (1), 27-33, 2006 | 711 | 2006 |
| Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary … S Guthikonda, CL Alviar, M Vaduganathan, M Arikan, A Tellez, T DeLao, ... Journal of the American College of Cardiology 52 (9), 743-749, 2008 | 435 | 2008 |
| Reticulated platelets and uninhibited COX‐1 and COX‐2 decrease the antiplatelet effects of aspirin S Guthikonda, EI Lev, R Patel, T DeLao, AL Bergeron, JF DONG, ... Journal of Thrombosis and Haemostasis 5 (3), 490-496, 2007 | 306 | 2007 |
| Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control JI Osende, JJ Badimon, V Fuster, P Herson, P Rabito, R Vidhun, A Zaman, ... Journal of the American College of Cardiology 38 (5), 1307-1312, 2001 | 244 | 2001 |
| Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice S Viskin, I Kitzis, E Lev, Z Zak, K Heller, Y Villa, A Zajarias, S Laniado, ... Journal of the American College of Cardiology 25 (6), 1327-1332, 1995 | 225 | 1995 |
| Genetic polymorphisms of the platelet receptors P2Y12, P2Y1 and GP IIIa and response to aspirin and clopidogrel EI Lev, RT Patel, S Guthikonda, D Lopez, PF Bray, NS Kleiman Thrombosis research 119 (3), 355-360, 2007 | 218 | 2007 |
| Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo … DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ... The Lancet 394 (10204), 1169-1180, 2019 | 204 | 2019 |
| Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary … EI Lev, R Kornowski, H Vaknin-Assa, A Porter, I Teplitsky, I Ben-Dor, ... The American journal of cardiology 102 (1), 6-11, 2008 | 193 | 2008 |
| Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy I Ben-Dor, NS Kleiman, E Lev The American journal of cardiology 104 (2), 227-233, 2009 | 185 | 2009 |
| Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamber MU Zafar, DA Vorchheimer, J Gaztanaga, M Velez, D Yadegar, ... Thrombosis and Haemostasis 98 (10), 883-888, 2007 | 155 | 2007 |
| Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix EI Lev, Z Estrov, K Aboulfatova, D Harris, JF Granada, C Alviar, ... Thrombosis and haemostasis 96 (10), 498-504, 2006 | 135 | 2006 |
| Acute antithrombotic effect of a front-loaded regimen of clopidogrel in patients with atherosclerosis on aspirin G Helft, JI Osende, SG Worthley, AG Zaman, OJ Rodriguez, EI Lev, ... Arteriosclerosis, thrombosis, and vascular biology 20 (10), 2316-2321, 2000 | 129 | 2000 |
| In vivo plaque characterization using intravascular ultrasound–virtual histology in a porcine model of complex coronary lesions JF Granada, D Wallace-Bradley, HK Win, CL Alviar, A Builes, EI Lev, ... Arteriosclerosis, thrombosis, and vascular biology 27 (2), 387-393, 2007 | 121 | 2007 |
| Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation EI Lev, A Solodky, N Harel, A Mager, D Brosh, A Assali, M Roller, A Battler, ... Journal of the American College of Cardiology 55 (2), 114-121, 2010 | 104 | 2010 |
| Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction L Perl, H Lerman-Shivek, E Rechavia, M Vaduganathan, D Leshem-Lev, ... Journal of the American College of Cardiology 63 (6), 513-517, 2014 | 100 | 2014 |
| Preparing hospitals for toxicological mass casualties events I Tur-Kaspa, EI Lev, I Hendler, R Siebner, Y Shapira, J Shemer Critical care medicine 27 (5), 1004-1008, 1999 | 88 | 1999 |
| Frequency, characteristics, and outcome of patients hospitalized with acute coronary syndromes with undetermined electrocardiographic patterns EI Lev, A Battler, S Behar, A Porter, M Haim, V Boyko, D Hasdai American Journal of Cardiology 91 (2), 224-227, 2003 | 86 | 2003 |
| Initial experience with a magnetic navigation system for percutaneous coronary intervention in complex coronary artery lesions SR Atmakuri, EI Lev, C Alviar, E Ibarra, AE Raizner, SL Solomon, ... Journal of the American College of Cardiology 47 (3), 515-521, 2006 | 79 | 2006 |
